STACHYDRINE HCL

ID: ALA166795

Max Phase: Preclinical

Molecular Formula: C7H14ClNO2

Molecular Weight: 143.19

Molecule Type: Small molecule

Associated Items:

Representations

Synonyms (1): Stachydrine HCl
Synonyms from Alternative Forms(1):

    Canonical SMILES:  C[N+]1(C)CCC[C@H]1C(=O)[O-].Cl

    Standard InChI:  InChI=1S/C7H13NO2.ClH/c1-8(2)5-3-4-6(8)7(9)10;/h6H,3-5H2,1-2H3;1H/t6-;/m0./s1

    Standard InChI Key:  DUNMULOWUUIQIL-RGMNGODLSA-N

    Associated Targets(Human)

    Cyclooxygenase-2 13999 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Associated Targets(non-human)

    Carnitine/acylcarnitine translocase 26 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Acetylcholinesterase 12221 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Cholinesterase 8742 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Molecule Features

    Natural Product: NoOral: NoChemical Probe: NoParenteral: No
    Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
    Chirality: NoAvailability: NoProdrug: No

    Drug Indications

    MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Properties

    Molecular Weight: 143.19Molecular Weight (Monoisotopic): 143.0946AlogP: -1.02#Rotatable Bonds: 1
    Polar Surface Area: 40.13Molecular Species: ACIDHBA: 2HBD: 0
    #RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
    CX Acidic pKa: 2.26CX Basic pKa: CX LogP: -3.88CX LogD: -3.11
    Aromatic Rings: 0Heavy Atoms: 10QED Weighted: 0.44Np Likeness Score: 1.35

    References

    1. Woster PM, Murray WJ..  (1986)  Synthesis and biological evaluation of cyclic analogues of 1-carnitine as potential agents in the treatment of myocardial ischemia.,  29  (5): [PMID:3084787] [10.1021/jm00155a045]
    2. Huss U, Ringbom T, Perera P, Bohlin L, Vasänge M..  (2002)  Screening of ubiquitous plant constituents for COX-2 inhibition with a scintillation proximity based assay.,  65  (11): [PMID:12444669] [10.1021/np020023m]
    3. Brunhofer G, Fallarero A, Karlsson D, Batista-Gonzalez A, Shinde P, Gopi Mohan C, Vuorela P..  (2012)  Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.,  20  (22): [PMID:23062825] [10.1016/j.bmc.2012.09.040]

    Source